Mohamed Zaki Adc Therapeutics Sa (ADCT) insider trading activity

ADCT Quotes by TradingView

Mohamed Zaki is Chief Medical Officer of ADC Therapeutics SA. Currently has a direct ownership of 462,888 shares of ADCT, which is worth approximately $814,682. The most recent transaction as insider was on Feb 13, 2025, when has been sold 230,000 shares (Common Shares) at a price of $1.61 per share, resulting in proceeds of $370,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 463K
n/a 3M change
n/a 12M change
Total Value Held $814,682

Mohamed Zaki Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2025
BUY
Grant, award, or other acquisition
$370,300 $1.61 p/Share
230,000 Added 33.19%
462,888 Common Shares
Dec 06 2024
SELL
Payment of exercise price or tax liability
$116,160 $3.13 p/Share
37,112 Reduced 13.75%
232,888 Common Shares
MZ

Mohamed Zaki

Chief Medical Officer
New Providence, NJ

Track Institutional and Insider Activities on ADCT

Follow ADC Therapeutics SA and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADCT shares.

Notify only if

Insider Trading

Get notified when an Adc Therapeutics Sa insider buys or sells ADCT shares.

Notify only if

News

Receive news related to ADC Therapeutics SA

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADCT